Table 2

Description and administration of measures

Domain

Measure

Screening/Enrollment

Pre-intervention

Post-intervention, Previsit

Post-visit

2-week Follow-up

6-week Follow-up

12-week Follow-up


Demographics

Age, race, sex, education, marital status

X


Average Pain

Numerical Analog Scale (0-10)

X

X

X

X

X

X

X


Worst Pain

Numerical Analog Scale (0-10)

X

X

X

X

X

X

X


Pain Severity

Mean of Average and Worst Pain

X

X

X

X

X

X

X


Pain Impairment

MOS Pain Impairment Scale

X

X

X

X

X


Anxiety

HADS Anxiety Subscale

X

X

X


Functional Status and Well-being

SF-12

X

X


Depression

PHQ-2 (not administered until Spring 2007)

X

X

X

X


Pain Beliefs

Brief Pain Barriers Questionnaire

X

X


Pain-Related Self-Efficacy

Derived from Anderson

X

X

X

X

X

X

X


General Adherence

MOS General Adherence

X

X

X


Communication Self-Efficacy

Maly

X

X

X

X

X

X

X


Analgesic Therapy

Chart review

X


Kravitz et al. BMC Cancer 2009 9:319   doi:10.1186/1471-2407-9-319

Open Data